Home / Health / Mandy Moore Advocates for Infant RSV Prevention Shot After Scary Diagnosis
Mandy Moore Advocates for Infant RSV Prevention Shot After Scary Diagnosis
17 Nov
Summary
- Mandy Moore's sons diagnosed with RSV in 2023, a "scary" experience
- Received Beyfortus antibody shot for newborn daughter to prevent RSV
- Beyfortus reduced RSV-related hospitalizations by 87% in clinical trials
In 2023, actress Mandy Moore and her family faced a frightening experience when her two sons were diagnosed with respiratory syncytial virus (RSV). Though her sons were not hospitalized, Moore was "rattled" by the severity of their illness and the potential complications.
When Moore became pregnant with her daughter, Louise "Lou," in 2024, she decided to be proactive. She learned about Beyfortus, a preventive non-vaccine antibody shot approved by the FDA in 2023, and decided to have Lou receive the treatment after her birth on October 1, 2025.
Beyfortus has shown remarkable results, reducing RSV-related hospitalizations and doctor visits by 87% in a recent study. Moore's pediatrician, Dr. Daniel Bruckner, has also seen a dramatic decrease in RSV hospitalizations in his own practice since offering the treatment.
For Moore, having the option to protect her newborn daughter was a "huge relief" compared to her previous pregnancies when no such preventive measure was available. She hopes her story will encourage other parents to discuss RSV prevention with their healthcare providers.
